OkamuraKSuzukiMChiharaT, Clinical evaluation of schizophyllan combined with irradiation in patients with cervical cancer. A randomized controlled study. Cancer1986; 58: 865–72.
2.
SuzukiMArikaTAmamiyaKFujiwaraM. Cooperative role of T-lymphocytes and macrophages in anti-tumor activity of mice pretreated with schizophyllan (SPG). Jpn J Exp Med1982; 52: 59–65.
3.
ShiozawaKShiozawaSShimizuSFujitaT. 1α,25-Dihydroxyvitamin D3 inhibits pokeweed mitogen-stimulated human B-cell activation: An analysis using serum-free culture conditions. Immunology1985; 56: 161–7.
4.
TanakaYShiozawaSMorimotoIFujitaT. Role of zinc in interleukin 2 (IL2)-mediated T-cell activation. Scand J Immunol1990; 31: 547–52.
5.
MuraguchiAKehrlJHButlerJLFauciAS. Regulation of human B-cell activation, proliferation, and differentiation by soluble factors. J Clin Immunol1984; 4: 337–47.
6.
JelinekDFLipskyPE. The role of B cell proliferation in the generation of immunoglobulin-secreting cells in man. J Immunol1983; 130: 2597–604.
7.
SakagamiYMizoguchiYShinT, Effects of an anti-tumor polysaccharide, schizophyllan, on interferon-gamma and interleukin 2 production by peripheral blood mononuclear cells. Biochem Biophys Res Commun1988; 155: 650–5.
